# Samsara BioCapital's Pharma Investments: 16 Startups in Its Portfolio (2026) > The 16 Pharma startups Samsara BioCapital has backed, by stage: $2.6B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/samsara-biocapital-pharma-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series B 7 - [Allakos](https://millionrounds.com/company/allakos) - [Claris Biotherapeutics](https://millionrounds.com/company/claris-biotherapeutics) - [Pathalys Pharma](https://millionrounds.com/company/pathalys-pharma) - [OrsoBio](https://millionrounds.com/company/orsobio) - [Rain Oncology](https://millionrounds.com/company/rain-oncology) - [Attralus](https://millionrounds.com/company/attralus) - [Enara Bio](https://millionrounds.com/company/enara-bio) ## Stage not reported 7 - [Mineralys Therapeutics](https://millionrounds.com/company/mineralys-therapeutics) - [Jade Biosciences](https://millionrounds.com/company/jade-biosciences) - [Inventiva Pharma](https://millionrounds.com/company/inventiva-pharma) - [HilleVax](https://millionrounds.com/company/hillevax) - [Mereo Biopharma](https://millionrounds.com/company/mereo-biopharma) - [Elevation Oncology](https://millionrounds.com/company/elevation-oncology) - [Enlaza Therapeutics](https://millionrounds.com/company/enlaza-therapeutics) ## Series C and later 2 - [ACELYRIN](https://millionrounds.com/company/acelyrin) - [Scholar Rock](https://millionrounds.com/company/scholar-rock) ## Segment by segment ### Series B 7 startups · $758M raised - [**Allakos**](https://millionrounds.com/company/allakos) Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases. United States $294M - [**Claris Biotherapeutics**](https://millionrounds.com/company/claris-biotherapeutics) Claris Biotherapeutics is a late-clinical stage biotechnology company based in Jersey City, New Jersey. United States $124M - [**Pathalys Pharma**](https://millionrounds.com/company/pathalys-pharma) Pathalys Pharma is a private biopharmaceutical company based in Raleigh, North Carolina, founded in 2021. United States $105M - [**OrsoBio**](https://millionrounds.com/company/orsobio) OrsoBio is a clinical-stage biopharmaceutical company focused on developing innovative therapies for severe metabolic disorders, i United States $67M - [**Rain Oncology**](https://millionrounds.com/company/rain-oncology) Rain Oncology is a clinical-stage company focusing on research and development of innovative therapies for cancer patients. - $63M - [**Attralus**](https://millionrounds.com/company/attralus) Attralus is a clinical-stage biopharmaceutical company focused on developing innovative medicines and diagnostics for systemic amyloidosis. United States $56M - [**Enara Bio**](https://millionrounds.com/company/enara-bio) Enara Bio Limited, based in Oxford, United Kingdom, is a biotechnology company focused on developing innovative cancer immunotherapies. United Kingdom $49M ### Stage not reported 7 startups · $1.4B raised - [**Mineralys Therapeutics**](https://millionrounds.com/company/mineralys-therapeutics) Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension. United States $788M - [**Jade Biosciences**](https://millionrounds.com/company/jade-biosciences) Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications. United States $195M - [**Inventiva Pharma**](https://millionrounds.com/company/inventiva-pharma) Inventiva Pharma is a biopharmaceutical company with several drug candidates at clinical and preclinical stage. France $120M - [**HilleVax**](https://millionrounds.com/company/hillevax) HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines. United States $100M - [**Mereo Biopharma**](https://millionrounds.com/company/mereo-biopharma) Mereo is a new UK-based speciality biopharmaceutical company. United Kingdom $92M - [**Elevation Oncology**](https://millionrounds.com/company/elevation-oncology) Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients. United States $50M - [**Enlaza Therapeutics**](https://millionrounds.com/company/enlaza-therapeutics) Enlaza Therapeutics is a biotechnology company based in La Jolla, California, focused on developing covalent protein biologics for United States $15M ### Series C and later 2 startups · $467M raised - [**ACELYRIN**](https://millionrounds.com/company/acelyrin) ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies. United States $300M - [**Scholar Rock**](https://millionrounds.com/company/scholar-rock) Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases. United States $167M **How this map is made.** Every startup here works in Pharma and has raised money in a round we track that names Samsara BioCapital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Samsara BioCapital's Biotech portfolio** 62 startups · $11B](https://millionrounds.com/portfolio-maps/samsara-biocapital-biotech-portfolio)[Co-investors **Who invests with Samsara BioCapital** 68 co-investors](https://millionrounds.com/portfolio-maps/samsara-biocapital-co-investors)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio)[Sector portfolio **Andreessen Horowitz's AI portfolio** 259 startups · $426B](https://millionrounds.com/portfolio-maps/andreessen-horowitz-ai-portfolio)[Sector portfolio **General Catalyst's AI portfolio** 226 startups · $179B](https://millionrounds.com/portfolio-maps/general-catalyst-ai-portfolio) ## Raising from investors like Samsara BioCapital? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)